ResMed Inc (ASX:RMD) & Magellan (ASX:MFG)
Owen Raszkiewicz
February 1, 2024
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
Uncharted territory for the Australian market
James Dunn
February 1, 2024
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed up 80.5 points, or 1.1 per cent, to 7,680.7 – 51.8 points, or 0.7 per cent, above the previous closing record of 7,628.9 points, which was reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) index added 77.8 points, or 1 per cent, to 7,912.8.
S&P/ASX 200 (INDEXASX:XJO) hits new all-time high
James Gerrish
January 31, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.06% to 7,680.70.
Should you buy Sigma Healthcare (ASX:SIG) shares before it merges with Chemist Warehouse?
Luke Laretive
January 31, 2024
Shares in pharmaceutical distribution company Sigma Healthcare Ltd (ASX: SIG) were on the move in December, rising 45% following the news of a potential $9 billion merger with Chemist Warehouse Group. SIG shares are in the spotlight again today, up a further 7% today.
7-Up for S&P/ASX 200 (INDEXASX:XJO)
James Dunn
January 31, 2024
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 21.8 points, or 0.3 per cent, to 7600.2 at the closing bell, with seven out of the 11 sectors finishing in the green. The All Ordinaries (INDEXASX: XAO) edged up 0.3 per cent.
Oil and gas lifts local market on Monday
James Dunn
January 30, 2024
The S&P/ASX 200 (INDEXASX: XJO) closed up 23 points, or 0.3 per cent, to 7578.4, around 50 points shy of its all-time high reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) gained 23.1 points, also 0.3 per cent, to 7,808.3.
S&P/ASX 200 (INDEXASX:XJO) higher ahead of reporting season
James Gerrish
January 29, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.30% to 7,578.40.
S&P/ASX 200 (INDEXASX:XJO) up: ResMed (ASX:RMD) & Min Res (ASX:MIN) impress
James Gerrish
January 25, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.48% to 7,555.40.
A choppy session as miners detail production results
James Gerrish
January 24, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.057% to 7,519.20.
ResMed Inc (ASX:RMD) & Magellan (ASX:MFG)
February 1, 2024
A deep dive into ResMed Inc (ASX: RMD) shares and Magellan Financial Group Ltd (ASX: MFG) shares by Rask’s Chief Investment Officer, Owen Rask.
Uncharted territory for the Australian market
February 1, 2024
The benchmark S&P/ASX 200 (INDEXASX: XJO) closed up 80.5 points, or 1.1 per cent, to 7,680.7 – 51.8 points, or 0.7 per cent, above the previous closing record of 7,628.9 points, which was reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) index added 77.8 points, or 1 per cent, to 7,912.8.
S&P/ASX 200 (INDEXASX:XJO) hits new all-time high
January 31, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.06% to 7,680.70.
Should you buy Sigma Healthcare (ASX:SIG) shares before it merges with Chemist Warehouse?
January 31, 2024
Shares in pharmaceutical distribution company Sigma Healthcare Ltd (ASX: SIG) were on the move in December, rising 45% following the news of a potential $9 billion merger with Chemist Warehouse Group. SIG shares are in the spotlight again today, up a further 7% today.
7-Up for S&P/ASX 200 (INDEXASX:XJO)
January 31, 2024
The benchmark S&P/ASX 200 (INDEXASX: XJO) index added 21.8 points, or 0.3 per cent, to 7600.2 at the closing bell, with seven out of the 11 sectors finishing in the green. The All Ordinaries (INDEXASX: XAO) edged up 0.3 per cent.
Oil and gas lifts local market on Monday
January 30, 2024
The S&P/ASX 200 (INDEXASX: XJO) closed up 23 points, or 0.3 per cent, to 7578.4, around 50 points shy of its all-time high reached in August 2021. The broader All Ordinaries (INDEXASX: XAO) gained 23.1 points, also 0.3 per cent, to 7,808.3.
S&P/ASX 200 (INDEXASX:XJO) higher ahead of reporting season
January 29, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.30% to 7,578.40.
S&P/ASX 200 (INDEXASX:XJO) up: ResMed (ASX:RMD) & Min Res (ASX:MIN) impress
January 25, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.48% to 7,555.40.
A choppy session as miners detail production results
January 24, 2024
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.057% to 7,519.20.
Like our podcast? Get Owen's weekly newsletter.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
